Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 4665 (MIR4665) is a short, non-coding RNA molecule classified as a microRNA, generally functioning to regulate gene expression post-transcriptionally by binding to partially complementary sequences in target mRNAs[1][3][5][6]. MicroRNAs typically inhibit mRNA translation or promote mRNA degradation, acting as fine tuners and buffers of protein output[4][6]. The MIR4665 gene is annotated in common databases, but little is known about its tissue distribution, biological functions, or roles in specific pathologies, distinguishing it from more widely-studied microRNAs. No clinical drugs or diagnostic applications are documented for MIR4665. MicroRNAs, including MIR4665, belong to a large family of molecules essential for gene regulation, development, and disease processes in humans[1][3][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 4665 (MIR4665).